Page 8 - Olink Explore News Today

In a recent study posted to the bioRxiv*preprint server, researchers evaluated the serum proteomic signatures of long coronavirus disease (COVID) patients.

(2022-05-09 | NDAQ:OLK) University of Oxford adopts Olink technology to advance protein biomarker discovery and unravel mechanisms of disease

Brokerages expect Olink Holding AB (publ) (NASDAQ:OLK – Get Rating) to post $20.14 million in sales for the current quarter, according to Zacks Investment Research. Two analysts have made estimates for Olink Holding AB (publ)’s earnings. Olink Holding AB (publ) reported sales of $13.63 million in the same quarter last year, which would suggest a […]

Olink Holding AB (publ) (NASDAQ:OLK – Get Rating) was upgraded by Zacks Investment Research from a “strong sell” rating to a “hold” rating in a report released on Wednesday, Zacks.com reports. According to Zacks, “Olink Holding AB provides a platform of products and services which are deployed across major biopharmaceutical companies and clinical and academic […]

Olink Holding AB (publ) (NASDAQ:OLK – Get Rating) had its price objective dropped by The Goldman Sachs Group from $34.00 to $20.00 in a research note issued to investors on Wednesday, Benzinga reports. The brokerage currently has a “neutral” rating on the stock. The Goldman Sachs Group’s price objective suggests a potential upside of 29.28% […]

Olink Holding AB (publ) (NASDAQ:OLK – Get Rating) is one of 42 publicly-traded companies in the “Analytical instruments” industry, but how does it weigh in compared to its competitors? We will compare Olink Holding AB (publ) to related companies based on the strength of its earnings, valuation, analyst recommendations, risk, institutional ownership, profitability and dividends. […]

Olink Holding AB (publ) (NASDAQ:OLK – Get Rating) is one of 42 public companies in the “Analytical instruments” industry, but how does it compare to its peers? We will compare Olink Holding AB (publ) to related companies based on the strength of its profitability, dividends, institutional ownership, earnings, analyst recommendations, risk and valuation. Profitability This […]

Olink Holding AB (publ) (NASDAQ:OLK – Get Rating) is one of 42 public companies in the “Analytical instruments” industry, but how does it weigh in compared to its rivals? We will compare Olink Holding AB (publ) to similar companies based on the strength of its earnings, analyst recommendations, valuation, risk, institutional ownership, profitability and dividends. […]

Olink Holding AB (publ) (NASDAQ:OLK – Get Rating) is one of 42 publicly-traded companies in the “Analytical instruments” industry, but how does it compare to its peers? We will compare Olink Holding AB (publ) to similar companies based on the strength of its earnings, dividends, risk, valuation, profitability, analyst recommendations and institutional ownership. Valuation & […]

Olink Holding AB (publ) (NASDAQ:OLK – Get Rating) is one of 42 public companies in the “Analytical instruments” industry, but how does it weigh in compared to its rivals? We will compare Olink Holding AB (publ) to related businesses based on the strength of its profitability, earnings, risk, valuation, institutional ownership, dividends and analyst recommendations. […]